Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Poseida Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 94 | 86 | −8 |
| Shares | 44.5M | 45.2M | +709.1K (+1.6%) |
| Value | $78.4M | $107.6M | +$29.2M (+37.3%) |
New holders (11)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 191,800 | $456.5K | 0.01% |
| Point72 Asset Management, L.P. | 100,000 | $238.0K | 0.00% |
| HSBC Holdings PLC | 48,937 | $116.2K | 0.00% |
| Franklin Resources Inc | 39,000 | $92.8K | 0.00% |
| Deutsche Bank AG | 35,880 | $85.4K | 0.00% |
| Prudential Financial Inc | 24,380 | $58.0K | 0.00% |
| STRS Ohio | 20,100 | $47.0K | 0.00% |
| Keystone Financial Group | 15,000 | $35.7K | 0.01% |
| Allspring Global Investments Holdings, LLC | 12,247 | $29.1K | 0.00% |
| Two Sigma Securities, LLC | 10,105 | $24.1K | 0.00% |
| Principal Financial Group Inc | 10,000 | $23.8K | 0.00% |
Sold out (19)
Institutions that held Poseida Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EcoR1 Capital, LLC | 676,296 | $1.19M |
| Two Sigma Investments, LP | 432,844 | $761.8K |
| Two Sigma Advisers, LP | 191,800 | $337.6K |
| Knott David M Jr | 140,921 | $248.0K |
| Arrowstreet Capital, Limited Partnership | 99,598 | $175.0K |
| Gsa Capital Partners LLP | 74,040 | $130.0K |
| UBS Asset Management Americas Inc | 39,000 | $120.1K |
| Globeflex Capital L P | 66,885 | $117.7K |
| Marshall Wace, LLP | 40,760 | $71.7K |
| Man Group plc | 31,450 | $55.4K |
| D. E. Shaw & Co., Inc. | 27,173 | $47.8K |
| Occudo Quantitative Strategies LP | 23,427 | $41.2K |
| Tucker Asset Management LLC | 19,096 | $33.6K |
| Graham Capital Management, L.P. | 19,038 | $33.5K |
| Susquehanna Fundamental Investments, LLC | 10,447 | $18.4K |
| Gladius Capital Management LP | 9,125 | $16.1K |
| Quent Capital, LLC | 2,000 | $3.52K |
| Impact Partnership Wealth, LLC | 270 | $475 |
| Simplex Trading, LLC | 157 | $0 |